Integrative Group (n = 40)

Control Group (n = 40)

Sex (Male/Female)

21/19

18/22

Age, years

41.33 ± 12.78

42.78 ± 12.34

Refractive error, D

−10.0 D

−10.0 D

Duration of symptoms, months

3.02 ± 1.58

3.56 ± 1.23

BCVA, letters

47.10 ± 13.51

42.90 ± 13.18

CRT, μm

370.73 ± 65.31

364.75 ± 69.31